| Literature DB >> 32936508 |
Anna M Rydzik1,2, Dirk Gottschling1, Eric Simon1, Wioletta Skronska-Wasek1, Jörg F Rippmann1, Doris Riether1.
Abstract
The introduction of N6-methyladenosine (m6 A) into siRNA targeting Factor VII impacts its potency in cells and has a significant influence on the selectivity of siRNA, including reduced off-targeting. These effects are dependent on the position of m6 A in the siRNA duplex, with some of the sequences identified as more potent and/or selective than their non-methylated counterpart. These findings broaden the repertoire of available chemical modifications for siRNA therapeutics and imply potential regulatory role of N6-methyladenosine in the RNAi pathways.Entities:
Keywords: antisense agents; epigenetics; methyladenosine; oligonucleotides; siRNA
Year: 2020 PMID: 32936508 DOI: 10.1002/cbic.202000551
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164